Publicaciones (23) Publicaciones de JEREMY DUFLOO -

2024

  1. Cell type-specific adaptation of the SARS-CoV-2 spike

    Virus Evolution, Vol. 10, Núm. 1

  2. Sex- and species-associated differences in complement-mediated immunity in humans and rhesus macaques

    mBio, Vol. 15, Núm. 3

  3. Temperature impacts SARS-CoV-2 spike fusogenicity and evolution

    mBio, Vol. 15, Núm. 4

2023

  1. Complement contributes to antibody-mediated protection against repeated SHIV challenge

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 20

  2. Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells

    Nature Communications, Vol. 13, Núm. 1

  2. Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis

    Nature Communications, Vol. 13, Núm. 1

  3. Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2

    Journal of Experimental Medicine, Vol. 219, Núm. 7

  4. Prix de thèses conjointes 2021 de la Société Française de Virologie et de l’ANRS | Maladies infectieuses émergentes

    Virologie (Montrouge, France), Vol. 26, Núm. 3, pp. 256-267

  5. Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers

    Nature Communications, Vol. 13, Núm. 1

2021

  1. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies

    Cell Reports Medicine, Vol. 2, Núm. 5

  2. Corrigendum to: Syncytia formation by SARS-CoV-2-infected cells (The EMBO Journal, (2020), 39, 23, 10.15252/embj.2020106267)

    EMBO Journal

  3. Functional heterogeneity of mammalian IFITM proteins against HIV-1

    Journal of Virology, Vol. 95, Núm. 18

  4. Revisiting an IgG Fc Loss-of-Function Experiment: The Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity

    mBio, Vol. 12, Núm. 5

  5. SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation

    EMBO Journal, Vol. 40, Núm. 24

2020

  1. A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

    Science Translational Medicine, Vol. 12, Núm. 559

  2. Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells

    EMBO Reports, Vol. 21, Núm. 2

  3. Diverse effects of interferon alpha on the establishment and reversal of HIV latency

    PLoS Pathogens, Vol. 16, Núm. 2

  4. Flow cytometry analysis of HIV-1 env conformations at the surface of infected cells and virions: Role of Nef, CD4, and SERINC5

    Journal of Virology, Vol. 94, Núm. 6

  5. Syncytia formation by SARS-CoV-2-infected cells

    EMBO Journal, Vol. 39, Núm. 23